297 related articles for article (PubMed ID: 11483794)
1. Economic evaluation of a 2-dose hepatitis B vaccination regimen for adolescents.
Levaux HP; Schonfeld WH; Pellissier JM; Cassidy WM; Sheriff SK; Fitzsimon C
Pediatrics; 2001 Aug; 108(2):317-25. PubMed ID: 11483794
[TBL] [Abstract][Full Text] [Related]
2. Costs of running a universal adolescent hepatitis B vaccination programme.
Wallace LA; Young D; Brown A; Cameron JC; Ahmed S; Duff R; Carman WF; Kitchin NR; Nguyen-Van-Tam JS; Goldberg DJ
Vaccine; 2005 Dec; 23(48-49):5624-31. PubMed ID: 16099079
[TBL] [Abstract][Full Text] [Related]
3. Prevention of hepatitis B virus transmission by immunization. An economic analysis of current recommendations.
Margolis HS; Coleman PJ; Brown RE; Mast EE; Sheingold SH; Arevalo JA
JAMA; 1995 Oct; 274(15):1201-8. PubMed ID: 7563509
[TBL] [Abstract][Full Text] [Related]
4. An economic evaluation of universal infant vaccination against hepatitis B virus using a combination vaccine (Hib-HepB): a decision analytic approach to cost effectiveness.
Harris A; Yong K; Kermode M
Aust N Z J Public Health; 2001 Jun; 25(3):222-9. PubMed ID: 11494989
[TBL] [Abstract][Full Text] [Related]
5. [Economic evaluation of various hepatitis B vaccination Strategies in Switzerland].
Zurn P; Danthine JP
Soz Praventivmed; 1998; 43 Suppl 1():S61-4, S134-7. PubMed ID: 9833269
[TBL] [Abstract][Full Text] [Related]
6. Costs and cost-effectiveness of a universal, school-based hepatitis B vaccination program.
Krahn M; Guasparini R; Sherman M; Detsky AS
Am J Public Health; 1998 Nov; 88(11):1638-44. PubMed ID: 9807529
[TBL] [Abstract][Full Text] [Related]
7. Should Canada and the United States universally vaccinate infants against hepatitis B? A cost-effectiveness analysis.
Krahn M; Detsky AS
Med Decis Making; 1993; 13(1):4-20. PubMed ID: 8433635
[TBL] [Abstract][Full Text] [Related]
8. Preventing Hepatitis B Virus Infection Among U.S. Military Personnel: Potential Impact of a 2-Dose Versus 3-Dose Vaccine on Medical Readiness.
Oelschlager KA; Termini MS; Stevenson C
Mil Med; 2023 Jul; 188(7-8):e2067-e2073. PubMed ID: 36525511
[TBL] [Abstract][Full Text] [Related]
9. Probabilistic cost-effectiveness analysis of the long-term effect of universal hepatitis B vaccination: an experience from Taiwan with high hepatitis B virus infection and Hepatitis B e Antigen positive prevalence.
Hung HF; Chen TH
Vaccine; 2009 Nov; 27(48):6770-6. PubMed ID: 19735755
[TBL] [Abstract][Full Text] [Related]
10. Cost-effectiveness of hepatitis B vaccination using HEPLISAV™ in selected adult populations compared to Engerix-B® vaccine.
Kuan RK; Janssen R; Heyward W; Bennett S; Nordyke R
Vaccine; 2013 Aug; 31(37):4024-32. PubMed ID: 23707166
[TBL] [Abstract][Full Text] [Related]
11. The cost-effectiveness of introducing hepatitis B vaccine into infant immunization services in Mozambique.
Griffiths UK; Hutton G; Das Dores Pascoal E
Health Policy Plan; 2005 Jan; 20(1):50-9. PubMed ID: 15689430
[TBL] [Abstract][Full Text] [Related]
12. [Economic evaluation on strategy for preventing mother-to-child transmission of hepatitis B in Zhejiang Province].
Zeng YB; Luo ML; He HQ; Deng X; Xie SY; Fang Y
Zhonghua Yu Fang Yi Xue Za Zhi; 2019 Jul; 53(7):706-712. PubMed ID: 31288342
[No Abstract] [Full Text] [Related]
13. Clinical and economic impact of a combination Haemophilus influenzae and Hepatitis B vaccine: estimating cost-effectiveness using decision analysis.
Fendrick AM; Lee JH; LaBarge C; Glick HA
Arch Pediatr Adolesc Med; 1999 Feb; 153(2):126-36. PubMed ID: 9988242
[TBL] [Abstract][Full Text] [Related]
14. The cost effectiveness of hepatitis immunization for US college students.
Jacobs RJ; Saab S; Meyerhoff AS
J Am Coll Health; 2003 May; 51(6):227-36. PubMed ID: 14510025
[TBL] [Abstract][Full Text] [Related]
15. Economic analysis of promotion of hepatitis B vaccinations among Vietnamese-American children and adolescents in Houston and Dallas.
Zhou F; Euler GL; McPhee SJ; Nguyen T; Lam T; Wong C; Mock J
Pediatrics; 2003 Jun; 111(6 Pt 1):1289-96. PubMed ID: 12777543
[TBL] [Abstract][Full Text] [Related]
16. Targeted outreach hepatitis B vaccination program in high-risk adults: The fundamental challenge of the last mile.
Mangen MJ; Stibbe H; Urbanus A; Siedenburg EC; Waldhober Q; de Wit GA; van Steenbergen JE;
Vaccine; 2017 May; 35(24):3215-3221. PubMed ID: 28483198
[TBL] [Abstract][Full Text] [Related]
17. School-based adolescent hepatitis B immunization programs in the United States: strategies and successes.
Cassidy W
Pediatr Infect Dis J; 1998 Jul; 17(7 Suppl):S43-6. PubMed ID: 9688100
[TBL] [Abstract][Full Text] [Related]
18. A hepatitis B vaccination program targeting adolescents.
Cassidy WM; Mahoney FJ
J Adolesc Health; 1995 Oct; 17(4):244-7. PubMed ID: 8580125
[TBL] [Abstract][Full Text] [Related]
19. 2-dose hepatitis vaccination versus 3-dose regimen.
Cruess DF
Pediatrics; 2002 Jun; 109(6):1183; author reply 1183-4. PubMed ID: 12042565
[No Abstract] [Full Text] [Related]
20. A cost-effectiveness analysis of hepatitis B vaccine in predialysis patients.
Oddone EZ; Cowper PA; Hamilton JD; Feussner JR
Health Serv Res; 1993 Apr; 28(1):97-121. PubMed ID: 8463111
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
